Use of indigestible oligosaccharides to reduce the incidence of

Details Use of indigestible oligosaccharides to reduce the incidence of Use of indigestible oligosaccharides to reduce the incidence of

1996-06-12

1998-12-15

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Food or edible as carrier for pharmaceutical

424442, 42419711, 4241951, 424441, 514 54, 426 73, 4263333, A61K 968

Patent

active

058493247

ABSTRACT:
A method is provided for reducing the incidence of otitis media in infants and young children by enterally administering indigestible fructooligosaccharides. More specifically, the present invention relates to a method for reducing the incidence of otitis media comprising administering to humans an indigestible fructooligosaccharide selected from the group consisting of 1-kestose, nystose and 1-.sup.F -B-fructofuranosyl nystose . The indigestible fructooligosaccharides can be produced through enzymatic synthesis, chemical techniques or isolated from plant materials and are administered in the form of a nutritional product, candy, tablets, chewing gums, lozenges, milk products, yogurts and the like. In a preferred embodiment of this invention, the fructooligosaccharides have a DP of 2 to 20 and still more preferably are the fructooligosaccharides FG.sub.2, GF.sub.3, and GF.sub.4.

REFERENCES:
patent: 4681771 (1987-07-01), Adachi et al.
patent: 4859488 (1989-08-01), Kan
patent: 5021245 (1991-06-01), Borschel et al.
patent: 5206355 (1993-04-01), Richards et al.
patent: 5219842 (1993-06-01), Okada et al.
patent: 5318794 (1994-06-01), Richards
patent: 5437880 (1995-08-01), Takaichi et al.
Hidaka, et al., "Effects of Fructooligosaccharides on Intestinal Flora and Human Health," Bifidobacteria Microflora 5(1):37-50, 1986.
Hidaka, et al., "The Effects of Undigestible Fructooligosaccharides on Intestinal Microflora and Various Physiological functions on Human Health," New Developments in Dietary Fiber, 105-177, 1990.
Hata and Nakajima, "Studies on Relationship Between Intake of Fructooligosaccharides and Abdominal Symptoms-Estimation of the Maximum Non-Effective Dose and 50% Laxative Effective Dose," Geriatric Medicine, vol. 23, No. 5: 817-828, 1985.
Tanaka, et al., "Utilization of Fructo-oligosaccharide from Mai-Meng-Dong by Intestinal Flora", Shoyakugaku Zasshi, 42(2), 143-146, 1988.
Coppa, et al., "Preliminary Study of Breastfeeding and Bacterial Adhesion to Uroepithelial Cells," abstr. The Lancet, vol. 335, 569-571, 1990.
Hidaka et al., "Proliferation of Bifidobacteria by Oligosaccharides and Their Useful Effect on Human Health," Bifidobacteria Microflora, vol. 10 (1), 65-79, 1991.
Hidaka, et al., "Fructooligosaccharides: Enzymatic preparation and Biofunctions," Journal of Carbohydrate Chemistry, 10(4): 509-522, 1991.
Speights, et al., "Fructooligosaccharides--A Low Caloric Building Agent--And More From Sucrose," Carbohydrates in Industrial Synthesis, ed. M.A. Clarke, Proceedings of the Symposium of the Division of Carbohydrate Chemistry of the American Chemical Society, 1992.
Kunz and Rudloff, "Biological functions of oligosaccharides in human milk," Acta Paediatr, 82:903-12 (1993).
Clevenger, et al., "Toxicological evaluation of neosugar: genotoxicity, carcinogenicity, and chronic toxicity," Journal of the American College of Toxicology, 7:643-662, 1988.

Affiliated with

Also associated with

Rating

Use of indigestible oligosaccharides to reduce the incidence of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of indigestible oligosaccharides to reduce the incidence of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of indigestible oligosaccharides to reduce the incidence of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1455308